Rick Beasley, MBA
Founded OBiS in 2001. Formerly Director of Oncology Market Research at Bristol-Myers Squibb. Extensive international experience having worked in over 50 countries throughout Asia, Europe and Latin America. BS Chemical Engineering, MBA Finance.
Tammy Gopen, PhD
Joined OBiS in 2004 as Clinical Director. She has conducted extensive clinical research in the Oncology field and has several publications in leading scientific journals. Her research has focused on the efficacy of chemotherapeutics in p53 positive cell lines. PhD in Molecular Biology from the City University of New York Graduate Center.
Hee Yun Suk, PhD
Joined OBiS in 2008. PhD in Molecular Pharmacology from Albert Einstein College of Medicine. Her thesis research and publications were in Metabolic Syndrome and related diseases (i.e. obesity, diabetes, cardiovascular diseases).
Michael Law
Joined OBiS in 2008. Extensive experience in multiple discipline areas in the IT field. Specializes in Java programming, Ruby programming, SQL server, Linux administration, Rails and SharePoint. BA in Computer Science from Queens College.
Tomoko Okano, MS
Joined OBiS in 2005 as Research Associate and specializes in China and Japan. MS Political Science from Columbia University.
Paul Yi
Joined OBiS in 2012. BS in Computer Science from Binghamton University.